Jyong Biotech Ltd.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | – | +0.8% | +4.1% | -5.5% | -16.7% | |
| – | – | – | – | – | – | |
| – | +2.9% | -17.3% | -17.0% | -13.4% | -21.1% | |
| – | -7.9% | +88.6% | +12.5% | -35.4% | +65.3% | |
| – | -1.7% | +17.7% | -1.1% | -26.5% | +21.9% | |
| – | – | – | – | – | – | |
| – | +0.4% | -8.4% | -1.0% | +36.7% | +145.3% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.